Cargando…
Time to Analgesia Onset and Pharmacokinetics After Separate and Combined Administration of Liposome Bupivacaine and Bupivacaine HCl: Considerations for Clinicians
BACKGROUND: Liposome bupivacaine is a prolonged-release bupivacaine formulation indicated for single-dose administration into the surgical site to produce postsurgical analgesia. METHODS: An overview of time to onset of analgesia observed with liposome bupivacaine in human studies is provided, as we...
Autores principales: | Gadsden, Jeffrey, Long, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897097/ https://www.ncbi.nlm.nih.gov/pubmed/27347237 http://dx.doi.org/10.2174/1874325001610010094 |
Ejemplares similares
-
Multimodal Analgesia in Breast Surgical Procedures: Technical and Pharmacological Considerations for Liposomal Bupivacaine Use
por: Afonso, Anoushka M., et al.
Publicado: (2017) -
Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia
por: Bergese, Sergio D, et al.
Publicado: (2012) -
Pharmacokinetics and Safety of INL-001 (Bupivacaine HCl) Implants Compared with Bupivacaine HCl Infiltration After Open Unilateral Inguinal Hernioplasty
por: Leiman, David, et al.
Publicado: (2020) -
Liposomal extended-release bupivacaine for postsurgical analgesia
por: Lambrechts, Mark, et al.
Publicado: (2013) -
Bupivacaine Pharmacokinetics and Breast Milk Excretion of Liposomal Bupivacaine Administered After Cesarean Birth
por: Mustafa, Hiba J., et al.
Publicado: (2020)